Spread of Extended-Spectrum b-lactamase Producing Klebsiella pneumoniae: Are b-lactamase Inhibitors of Therapeutic Value?
|
|
- Candice Patrick
- 6 years ago
- Views:
Transcription
1 76 Spread of Extended-Spectrum b-lactamase Producing Klebsiella pneumoniae: Are b-lactamase Inhibitors of Therapeutic Value? Lionel Piroth, Hervé Aubé, Jean-Marc Doise, and Michel Vincent-Martin From Service de Réanimation Médicale, Centre Hospitalo-Universitaire de Dijon, Dijon, France Because of recurrent colonization by Klebsiella pneumoniae strains producing type SHV-4 extended-spectrum b-lactamases (ESBLs), a case-control study was conducted in an intensive care unit to investigate the risk of acquisition, with special reference to antibiotic therapy and resuscitation procedures. Fifty-one patients colonized or infected by ESBL-producing K. pneumoniae (cases) were matched with 51 noncolonized patients (controls). Duration of intubation was significantly longer for cases than for controls, while duration of b-lactamase inhibitor therapy was significantly shorter. By means of multivariate analysis, intubation was the only risk factor identified (odds ratio [OR] Å 1.19), while b-lactamase inhibitor therapy was shown to be a protective factor (OR Å 0.849). During outbreaks of SHV-4 type ESBL producing K. pneumoniae in intensive care units, preferential use of b-lactamase inhibitors may help control the emergence and spread of these pathogens even if essential hand washing and isolation procedures are adhered to. variate analysis only [2]. Most of these studies [17 19] were not designed to standardize the main risk factors for nosocomial infections as duration of stay or severity of disease. Nonetheless, it is of particular interest to know which drugs are poten- tially associated with acquisition of ESBL-producing K. pneumoniae to determine preferential empirical treatment. A case-control study was conducted in our ICU to investigate the risk factors for transmission of ESBL-producing K. pneu- moniae with special reference to antibiotic therapy and technical procedures; the study was designed to standardize known risk factors such as duration of exposure and severity of disease was also investigated. Nosocomial infection due to enterobacteria producing extended-spectrum b-lactamases (ESBLs), particularly Klebsiella species, has become more prevalent. These infections are of particular concern in intensive care units (ICUs) but also in other wards such as geriatric wards and nursing homes where stays are medium and long term [1]. Nosocomial infections with ESBL-producing Klebsiella pneumoniae are difficult to eradicate because these organisms develop resistance to multiple antibiotics. Effective control can be achieved only through more thorough understanding of the transmission process. See editorial response by Jacoby on pages The study was carried out at the medical ICU of the Dijon University Hospital (Dijon, France), an 11-bed unit with an average annual admittance of Ç550 adult patients. An active control program was introduced in December 1993, including systematic identification (by culturing of stool specimens ob- tained at admission and at least once a week) of colonization with ESBL-producing K. pneumoniae and isolation of all pa- tients with infection or colonization until their discharge from the ICU. In the study by Schiappa et al. [2], one risk factor for acquiring ESBL-producing K. pneumoniae was duration of stay in the hospital. Equipment such as artificial ventilation apparatuses, catheters, and cannulas [2 6] and nursing care work load [2] were also suggested as likely risk factors. In many studies [5, 7 14], the impact of antibiotics on acquiring ESBL-producing K. pneumoniae was questioned on the basis of historical or indirect arguments: etiologic investigations that included antibiotic administration as a risk factor gave conflicting results. In some studies, antibiotic therapy and colonization by ESBL-producing K. pneumoniae were not significantly associated [15]. In other studies, colonization was demonstrated to be associated with antibiotic therapy with no precision of antibiotic class [3, 6, 16], with sulfonamides and fluoroquinolones [4], or with cephalosporins by means of uni- Materials and Methods Setting Bacteriologic Data In every suspected case of infection or colonization, multiple routine bacteriologic specimens were tested for Klebsiella by Received 14 October 1997; revised 16 March means of the API System (biomérieux, Marcy l Etoile, France). Reprints or correspondence: Dr. Hervé Aubé, Service de Réanimation Médi- Susceptibility of each K. pneumoniae strain to antibiotics was cale, Hôpital Général, B.P. 1519, Dijon Cedex, France. tested by using the agar disk diffusion method, the results Clinical Infectious Diseases 1998;27:76 80 of which were interpreted according to French recommended 1998 by the Infectious Diseases Society of America. All rights reserved /98/ $03.00 standards [20]. The double-disk synergy test described by Le-
2 CID 1998;27 (July) b-lactamase Inhibitors for ESBL-Producing K. pneumoniae 77 grand et al. [21] was used to detect ESBL-producing strains. Strains of ESBL-producing K. pneumoniae were also identified by pulsed field gel electrophoresis. ESBLs were typed by comparing their isoelectric points with those of reference ESBLs. Clinical Data All medical records for every patient admitted to the ICU from 1 January 1994 to 1 September 1996 were examined. Gender, age, admission route, simplified acute physiological score (SAPS) at the time of admission, presentation disorder(s), duration of stay, microorganisms identified in bacteriologic specimens and site and date of isolation, technical procedures, number of days of treatment, and course of the disease were all recorded. Results were recorded in terms of percentage for qualitative variables and mean { SD for quantitative variables. With use of the standardized mortality ratio (SMR), the mortality rate among patients infected with ESBL-producing K. pneumoniae was compared with the expected rate among the ICU population as a whole (reference population) following indirect standardization. Univariate analysis was performed by using Wilcoxon s testing of variables for matched pairs to compare and identify factors significantly associated with development of infection or colonization with ESBL-producing K. pneumoniae. Multivariate analysis was carried out by means of logistic regression of variables for matched pairs with backward stepping. The final model included all matching variables. Results Cases and Controls A patient from whom ESBL-producing K. pneumoniae was Descriptive Epidemiology isolated at least once during the ICU stay, whatever the isola- From 1 January 1994 to 1 September 1996, 1,533 patients tion site and the inflammatory response, was defined as a case. were admitted to the medical ICU of Dijon University Hospital. Colonized and infected patients were included in the study. Of these patients, 54 (3.5%) were ESBL-producing K. pneumoniae Cases were regarded as community acquired when evidence carriers. The mean age { SD of these 54 patients was of ESBL-producing K. pneumoniae was demonstrated within 66 { 14 years; 63% were men; and the average SAPS { SD the first 48 hours of admission to the ICU. After this time, was 15.1 { 4. The mean duration of stay in the ward { SD the case was considered as hospital acquired. Only hospital- was 23 { 27 days. One of the 54 carriers had a communityacquired acquired cases were included in the study. case; the remaining 53 had hospital-acquired cases. Every case was matched with a control in terms of age ({4 The average time for acquisition was 15.8 days (range, 3 87 years), gender, SAPS ({3), presentation disorder(s) (including days). presence or absence of infection), and length of exposure. K. pneumoniae represented 8.7% of the total number of Length of exposure for controls was defined as a period that bacterial strains isolated, irrespective of site. Of these strains, was at least equal to the period before contamination for cases. 55% produced ESBLs. ESBL-producing K. pneumoniae was For controls, absence of ESBL-producing K. pneumoniae was isolated from the following specimens from the 54 carriers: demonstrated by bacteriologic specimens throughout their stay feces, 42 patients (78%); urine, 12 (22%); bronchi, 11 (20%); in the ward. and blood or other sites, 4 (7%). Three different antibiotypes Controls were selected by an independent observer on the were demonstrated. The most frequent antibiotype (60% of sole basis of matching criteria, other variables being unknown. strains) showed resistance to b-lactam agents (with the excep- Should several potential controls meet the matching criteria, tion of cephamycin and imipenem), resistance to aminoglycosides that control whose admission date was closest to that of the (except for gentamicin), and resistance to quinolones and case was selected. When no suitable control met the matching fluoroquinolones, sulfonamides, and chloramphenicol. Only criteria, the case was excluded from the study. one ESBL-producing strain was identified by pulsed field gel electropheresis throughout the ward. The ESBL was SHV-4. Risk Factors Of the 1,533 inpatients, 49% received antibiotic therapy during their stay in the ICU (64% of 872 patients who stayed for Risk factors such as number of days of use of third-generation ú48 hours). The most frequently used antibiotic classes in the cephalosporins, penicillins, b-lactamase inhibitors, amino- ICU during the study period were penicillins (alone in 15% of glycosides, fluoroquinolones, deep-venous catheters, indwelling cases or in combination with b-lactamase inhibitors in 19%), urinary catheters, and endotracheal tubes were investigated. third-generation cephalosporins (22%), aminoglycosides (19%), and systemic fluoroquinolones (16%). Of the 53 patients Data Analysis who had hospital-acquired cases, 84% had received antibiotic treatment prior to colonization. Statistical analysis was performed by using Epi-Info version The crude mortality rate was 32% among patients colonized 5.1 (Centers for Disease Control and Prevention, Atlanta) and or infected with ESBL-producing K. pneumoniae and 26% BMDP (BMDP, West Los Angeles). among noninfected patients. Following indirect standardization
3 78 Piroth et al. CID (July) Table 1. General characteristics of cases and controls in a study Table 3. Results of multivariate analysis with logistic regression in of b-lactamase inhibitor therapy and infection or colonization with a case-control study of b-lactamase inhibitor therapy and infection extended-spectrum b-lactamase producing Klebsiella pneumoniae. or colonization with extended-spectrum b-lactamase producing Klebsiella pneumoniae. Characteristic Cases Controls P value Variable Coefficient { SE OR P value No. of patients Mean age (y) { SD 65.8 { { b-lactamase inhibitor (/1 d) { No. of males/no. of females 32/19 32/ Intubation (/1 d) { Mean SAPS { SD 15.5 { { No. (%) with infectious NOTE. /1 då augmentation of the coefficient for 1 day of treatment. disease at admission 12 (24) 12 (24) 1.00 Mean length of exposure (d) { SD 13.1 { { No. (%) treated with By means of multivariate analysis with logistic regression, antibiotics 43 (84) 45 (88).57 the significant factors were intubation (risk factor) and previous use of b-lactamase inhibitors (protective factor) (table 3). No NOTE. SAPS Å simplified acute physiological score. interaction was found among use of b-lactamase inhibitors, use of third-generation cephalosporins, and intubation. of SAPS and duration of stay, the SMR was not statistically significant. Discussion Epidemiological data (especially bacteriologic data) re- Case-Control Study corded in our ward during the period 1 January 1994 to 1 There were 51 cases. Apart from the patient with a commusame September 1996 revealed major characteristics that were the nity-acquired case, two other patients colonized by ESBL-probreaks as those previously reported following recurrent out- ducing K. pneumoniae were excluded because there was no of ESBL-producing K. pneumoniae since 1983: namely, suitable control who met the matching criteria. Fifty-one of resistance to third-generation cephalosporins, aminoglycosides, 186 potential controls were selected for the study. The general sulfonamides, and chloramphenicol [10, 12, 22]; type of encharacteristics of these groups are shown in table 1. zyme (SHV-4, which is commonly isolated in France) [5, 10, By means of univariate analysis (table 2), only the intubation 23 25]; main isolation sites [5, 9 12, 15, 22, 26, 27]; and period was significantly longer for cases than for controls, average contamination period [4, 5, 9, 11, 26]. An increase whereas the duration of b-lactamase inhibitor therapy was sigproducing in the mortality rate associated with infection due to ESBL- nificantly shorter. The b-lactamase inhibitors used by either K. pneumoniae was reported previously [2], but this group were clavulanic acid (80% of patients) and tazobactam increase was not documented in this study following standard- (20%). Agents used in association with b-lactamase inhibitors ization because it was attributable to the severity of underlying were amoxicillin (76% of patients) and piperacillin or ticarcillin diseases. (24%). Third-generation cephalosporins were never used in Intubation was the major risk factor in the spread of ESBLcombination with b-lactamase inhibitors. producing K. pneumoniae, implying that colonized patients be- Table 2. Results of univariate analysis in a case-control study of long to the most critically ill ICU population. This factor is independent from the type of antibiotic therapy given. Mouth care and enteral feeding of intubated patients are likely to b-lactamase inhibitor therapy and infection or colonization with ex- increase the risk of cross-infection by contact transfer. This tended-spectrum b-lactamase producing Klebsiella pneumoniae. observation points out the importance of hand transmission of ESBL-producing K. pneumoniae and therefore hand washing Mean no. of days in the critical care setting. of use { SD Whether patients were intubated, previous use of b-lacta- Variable Cases Controls P value mase inhibitors was a protective factor against acquisition of SHV-4 type ESBL producing K. pneumoniae. Penicillins were Penicillins 4.6 { { always given in combination with b-lactamase inhibitors in Third-generation cephalosporins 1.4 { { our study, but these agents had no protective effect as shown Aminoglycosides 1.4 { { Fluoroquinolones 1.7 { { in the univariate and multivariate analyses. To our knowledge, b-lactamase inhibitors 3.0 { { this specific role of b-lactamase inhibitors has not been re- Intubation 11.4 { { ported in any etiologic study, since these agents are seldom Catheter 9.9 { { analyzed on their own. It is not however surprising that patients Urinary catheter 8.1 { { receiving an active drug would not be infected with the suscep-
4 CID 1998;27 (July) b-lactamase Inhibitors for ESBL-Producing K. pneumoniae 79 tible pathogen. By inhibiting ESBLs, b-lactamase inhibitors association with penicillins may help control outbreaks of appear to impair the emergence and spread of Klebsiella carrying ESBL-producing K. pneumoniae, in particular SHV-4 type resistance plasmids [28, 29]. Furthermore, administration ESBL producing K. pneumoniae. In the absence of an out- of b-lactamase inhibitors and penicillin may exert in vitro pressure break, the risk for the emergence of resistant pathogens seems on ESBLs, thereby facilitating their reverse mutation into to be far higher than the expected benefit to recommend the less harmful enzymes [30]. On the other hand, some clinical systematic use of b-lactamase inhibitors in empirical treat- isolates of ESBL-producing K. pneumoniae were found to be ments. The results of this study call for further investigations less susceptible to b-lactam b-lactamase inhibitor combinations such as multicenter and prospective trials. because of hyperproduction of ESBLs [31, 32], but the role of previous b-lactamase inhibitor treatment in this emerging resistance has not yet been established. There is also risk for References a selection effect on gram-negative rods producing plasmidic or 1. Jacoby GA, Medeiros AA. More extended-spectrum b-lactamases. Antimichromosomic AmpC type b-lactamases [28]. crob Agents Chemother 1991;35: Findings of this study must be put into perspective because 2. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant of several limitations. First, only one clonal strain of ESBLcase-control Klebsiella pneumoniae and Escherichia coli bloodstream infection: a and molecular epidemiologic investigation. J Infect Dis producing K. pneumoniae that produced a single type of ESBL 1996;174: (SHV-4) was observed and investigated. It is not possible to 3. Lucet JC, Chevret S, Vanjak D, et al. Risk factors for acquiring extendedstate if the conclusion is valid for other types of ESBL-produc- spectrum beta-lactamases Enterobacteriaceae (ESBLE) in ICU [abstract ing K. pneumoniae or ESBLs. Second, the small population no 637]. In: Program and abstracts of the 32nd Interscience Conference size generated a lack of power, especially regarding the use of on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washing- ton, DC: American Society for Microbiology, 1992:217. third-generation cephalosporins, aminoglycosides, and fluoro- 4. De Champs C, Rouby D, Guelon D, et al. A case-control study of an quinolones. Last, cases included patients who acquired SHVoutbreak of infections caused by Klebsiella pneumoniae strains produc- 4 type ESBL producing K. pneumoniae following either alter- ing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991;18:5 13. ation of the endogenous flora or patients colonized via exogeinfections 5. Arlet G, Sanson Le Pors MJ, Rouveau M, et al. Outbreak of nosocomial nous routes. Since mechanisms of acquisition are different, risk due to Klebsiella pneumoniae producing SHV-4 beta-lacta- mase. Eur J Clin Microbiol Infect Dis 1990;9: factors are likely to be different too. However, one would be 6. Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of inclined to think that antibiotic therapy prior to acquisition Klebsiella pneumoniae producing extended-spectrum beta-lactamase alters the modes of both endogenous development and exoge- (ESBL-KP) in the intensive care unit. J Hosp Infect 1997;35:9 16. nous spread of infection due to ESBL-producing K. pneumon- 7. De Champs C, Sauvant MP, Chanal C, Sirot D, Gazuy N, Malhuret R. iae. Furthermore, since presentation disorders, severity of disspectrum-b-lactamase-producing Prospective survey of colonisation and infection caused by expandedease, members of the family Enterobacteri- and length of exposure were fairly similar in both groups, aceae in an intensive care unit. J Clin Microbiol 1989;27: it could be supposed that nursing care work load was similar 8. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak too and that exposure to cross-infection through contact transfer of Klebsiella infection resistant to late-generation cephalosporins. Ann was equal in each matched case-control pair. Intern Med 1993;119: Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A. Epidemiology of extended-spectrum b-lactamases. Infection 1989;17: Conclusion 10. Brun-Buisson C, Legrand P, Philippon A, Legrand P, Montravers F, Duval This study suggests that b-lactamase inhibitors may have a J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. protective effect against acquiring SHV-4 type ESBL produc- Lancet 1987;2: ing K. pneumoniae, especially in intubated patients in ICUs. 11. Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G. Klebsiella pneu- moniae and other Enterobacteriaceae producing novel plasmid-mediated The therapeutic value of b-lactamase inhibitors must be pointed b-lactamases markedly active against third-generation cephalosporins: out not only for the management of infection or colonization epidemiologic studies. Rev Infect Dis 1988;10: with ESBL-producing K. pneumoniae [28, 33 36] but also for 12. Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime conventional antibiotic therapy. It is of particular interest that resistance due to a novel extended-spectrum b-lactamase in isolates some investigators [14] recently used this approach (with piper- from cancer patients. Antimicrob Agents Chemother 1992;36: Quinn JP. Clinical significance of extended-spectrum beta-lactamases. Eur acillin and tazobactam rather than ceftazidime) in the empirical J Clin Microbiol Infect Dis 1994;13(suppl 1):S treatment of nosocomial infections. Such an approach resulted 14. Rice LB, Eckstein EC, De Vente J, Shlaes DM. Ceftazidime-resistant in a significant decrease in colonizations with K. pneumoniae Klebsiella pneumoniae isolates recovered at the Cleveland Department (producing SHV-4 and TEM-derived ESBLs) without in- of Veterans Affairs Medical Center. Clin Infect Dis 1996;23: creased resistance to b-lactamase inhibitors in the clinical iso- 15. Venezia RA, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum b-lactamase in Enterobacteriaceae isolated lates. from infants in an neonatal intensive care unit. Clin Infect Dis 1995; Even if essential hand washing and isolation procedures are 21: adhered to for preventing and limiting nosocomial infections, 16. Hibberd PL, Jacoby GA. Multiple drug resistant Klebsiella pneumoniae we conclude that preferential use of b-lactamase inhibitors in (MDRKP) strains: predictors of acquisition and mortality [abstract no
5 80 Piroth et al. CID (July) C46]. In: Program and abstracts of the 34th Interscience Conference on 3-year survey in France. Antimicrob Agents Chemother 1992;36:1677 Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, 81. DC: American Society for Microbiology, 1994: Livermore DM. b-lactamases in laboratory and clinical resistance. Clin 17. Freeman J, Mc Gowan JE. Risk factors for nosocomial infection. J Infect Microbiol Rev 1995;8: Dis 1978;138: Goldstein FW, Pean Y, Rosato A, Gertner J, Gutmann L, the Vigil Roc 18. Maki DG. Risk factors for nosocomial infection in intensive care. Arch Study Group. Characterization of ceftriaxone-resistant Enterobacteria- Intern Med 1989;149:30 3. ceae: a multicentre study in 26 French hospitals. J Antimicrob Chemoter 19. French GL, Cheng AFB, Wong SL, Donnan S. Repeated prevalence sur- 1993;32: veys for monitoring effectiveness of hospital infection control. Lancet 30. Du Bois SK, Mariott MS, Amyes SGB. TEM- and SHV-derived extended- 1989;2: spectrum b-lactamases: relationship between selection, structure and 20. Acar J, Bergogne-Berezin E, Chabbert Y, et al. Communiqué 1992 du function. J Antimicrob Chemother 1995;35:7 22. Comité de l Antibiogramme de la société Française de Microbiologie. 31. Rice LB, Carias LL, Bonomo RA, Shlaes DM. Molecular genetics of Pathol Biol (Paris) 1992;40: resistance to both ceftazidime and b-lactam b-lactamase inhibitor com- 21. Legrand P, Fournie G, Bure A, et al. Detection of extended broad-spectrum binations in Klebsiella pneumoniae and in vivo response to b-lactam beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J therapy. J Infect Dis 1996;173: Clin Microbiol Infect Dis 1989;8: French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and b-lactam- 22. Decre D, Arlet G, Pernet M, Calvez H, Bergogne-Berezin E, Regnier B. b-lactamase inhibitor combinations by hyperproduction of SHV-5 b- Epidémiologie des souches de Klebsiella pneumoniae productrices de lactamase. J Clin Microbiol 1996;34: beta-lactamase à spectre élargi en réanimation. Rean Urg 1993;2: Rice LB, Carias LL, Shlaes DM. In vivo efficacies of b-lactam-b-lacta- 23. Garau J. Beta-lactamases: current situation and clinical importance. Intenmase inhibitor combinations against a TEM-26-producing strain of sive Care Med 1994;20(suppl 3):S5 9. Klebsiella pneumoniae. Antimicrob Agents Chemother 1994;38: 24. Arlet G, Rouveau M, Casin I, et al. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were 34. Jett BJ, Ritchie DJ, Reichley R, Bailey TC, Sahm SF. In vitro activities isolated in 14 French hospitals. J Clin Microbiol 1994;32: of various b-lactam antimicrobial agents against clinical isolates of 25. Thabaut A, Acar J, Allouch P, et al. Fréquence et distribution des betalacta- Escherichia coli and Klebsiella spp. resistant to oxyiminocephalospormases chez 1792 souches de Klebsiella pneumoniae isolées en France ins. Antimicrob Agents Chemother 1995;39: entre 1985 et Pathol Biol (Paris) 1990;38: Bauernfeind A. Perspectives of beta-lactamase inhibitors in therapy of 26. Jacoby GA. Characteristics of an outbreak of multidrug resistant Klebsiella infections caused by Escherichia coli or Klebsiella with plasmidic resispneumoniae (MDRKP) infections [abstract no C48]. In: Program and tance to third-generation cephalosporin. Infection 1990;18: abstracts of the 34th Interscience Conference on Antimicrobial Agents 36. Leleu G, Kitzis MD, Vallois JM, Gutmann L, Decazes JM. Different ratios and Chemotherapy (Orlando, FL). Washington, DC: American Society of the piperacillin-tazobactam combination for treatment of experimenfor Microbiology, 1994:88. tal meningitis due to Klebsiella pneumoniae producing the TEM-3 ex- 27. Sirot DL, Goldstein FW, Soussy CJ, et al. Resistance to cefotaxime and tended-spectrum b-lactamase. Antimicrob Agents Chemother 1994;38: seven other b-lactams in members of the family Enterobacteriaceae: a
Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing Extended- Spectrum -Lactamases
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1998, p. 53 58 Vol. 42, No. 1 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology Epidemiology and Successful Control of a Large Outbreak
More informationJOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p. 2575 2579 Vol. 36, No. 9 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Can Results Obtained with Commercially
More informationOvercoming the PosESBLities of Enterobacteriaceae Resistance
Overcoming the PosESBLities of Enterobacteriaceae Resistance Review of current treatment options Jamie Reed, PharmD Pharmacy Grand Rounds August 28, 2018 Rochester, MN 2018 MFMER slide-1 Disclosure No
More informationPrevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital
More informationMolecular characterisation of CTX-M-type extendedspectrum β-lactamases of Escherichia coli isolated from a Portuguese University Hospital
EJHP Science Volume 17 2011 Issue 3 P. 1-5 2011 Pharma Publishing and Media Europe. All rights reserved 1781-7595 25 www.ejhp.eu Molecular characterisation of CTX-M-type extendedspectrum β-lactamases of
More informationZ. Daoud 1 and N. Hakime 2
Rev Esp Quimioterap, Junio 2003; Vol.16 (Nº 2): 233-238 2003 Prous Science, S.A.- Sociedad Española de Quimioterapia Original Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing
More informationEpidemiology of ESBL in hospitals and in the community
Epidemiology of ESBL in hospitals and in the community Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L C Y M R
More informationPredictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2006, p. 1715 1720 Vol. 50, No. 5 0066-4804/06/$08.00 0 doi:10.1128/aac.50.5.1715 1720.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known
More informationEmergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH
Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.
More information(DHA-1): Microbiologic and Clinical Implications
AAC Accepts, published online ahead of print on 20 September 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.00083-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationRevised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in
AAC Accepts, published online ahead of print on 3 December 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01180-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationDiscussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category
Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationEnterobacteriaceae in Bamako, Mali. Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, CHU Reims, UFR Médecine
AAC Accepts, published online ahead of print on 31 August 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.00675-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationPublic Health Surveillance for Multi Drug Resistant Organisms in Orange County
Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action
More informationbreakpoints, cephalosporins, CLSI, Enterobacteriacae, EUCAST, review Clin Microbiol Infect 2008; 14 (Suppl. 1):
REVIEW Breakpoints for intravenously used cephalosporins in Enterobacteriaceae EUCAST and CLSI breakpoints G. Kahlmeter Department of Clinical Microbiology, Central Hospital, Växjö, Sweden ABSTRACT It
More informationFrom the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital
From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures
More informationDevelopment of a phenotypic method for fecal carriage detection of OXA-48-producing
JCM Accepts, published online ahead of print on 11 May 2011 J. Clin. Microbiol. doi:10.1128/jcm.00055-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014.
Annual survey of extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae, 2013 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research
More informationSensitivity of Surveillance Testing for Multidrug-Resistant Gram-Negative Bacteria in the
JCM Accepts, published online ahead of print on 20 August 2014 J. Clin. Microbiol. doi:10.1128/jcm.02369-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Sensitivity of Surveillance
More informationCarbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.
JCM Accepts, published online ahead of print on 7 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02878-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Carbapenem Disks
More informationUpdate on CLSI and EUCAST
Update on CLSI and EUCAST 1 Completed work» Cephalosporin breakpoints for Enterobacteriaceae ESBL screens MIC versus resistance mechanism» Carbapenem breakpoints for Enterobacteriaceae Modified Hodge Test»
More informationKlebsiella pneumoniae 21 PCR
2011 11 TEM-132 ESBL Klebsiella pneumoniae 1) 2) 1) 1) 3) 2) 1) 2) 3) 19 6 27 22 10 20 2003 4 2004 11 95 ceftazidime (CAZ) Klebsiella pneumoniae 21 PCR b- (ESBL) PCR (PFGE) PCR bla TEM-132 PFGE 19 TEM-132
More informationALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella
ALERT Clinical microbiology considerations related to the emergence of New Delhi metallo beta lactamases (NDM 1) and Klebsiella pneumoniae carbapenemases (KPC) amongst hospitalized patients in South Africa
More informationjmb Research Article Review Semi Kim 1, Ji Youn Sung 2, Hye Hyun Cho 3, Kye Chul Kwon 1, and Sun Hoe Koo 1 *
J. Microbiol. Biotechnol. (2014), 24(6), 765 770 http://dx.doi.org/10.4014/jmb.1306.06036 Review Research Article jmb Characterization of CTX-M-14- and CTX-M-15-Producing Escherichia coli and Klebsiella
More informationEnterobacter aerogenes
Enterobacter aerogenes Piagnerelli M 1, Carlier E 1, Deplano A 3, Lejeune P 1, Govaerts D 2 1 Departments of Intensive Care and 2 Microbiology, A. Vésale Hospital. 6110 Montigny-le-Tilleul. 3 Department
More informationDisclosure. Objectives. Evolution of β Lactamases. Extended Spectrum β Lactamases: The New Normal. Prevalence of ESBL Mystic Program
47 th Annual Meeting August 2-4, 2013 Orlando, FL Extended Spectrum β Lactamases: The New Normal Disclosure I do have a vested interest in or affiliation with the following companies or organizations Triax
More informationImpact of Extended Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Infections in Severely Burned Patients
Impact of Extended Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Infections in Severely Burned Patients Jason W Bennett, MD, MSPH, Janelle L Robertson, MD, Duane R Hospenthal, MD, PhD, Steven
More informationPROFESSOR PETER M. HAWKEY
Multi-drug resistant Escherichia coli PROFESSOR PETER M. HAWKEY School of Immunity and Infection College of Medical and Dental Sciences University of Birmingham Birmingham B15 2TT Health Protection Agency
More informationCharacterization of ceftriaxone-resistant Enterobacteriaceae: a molticentre study in 26 French hospitals
Journal of Antimicrobial Chemotherapy (99), 9-0 Characterization of ceftriaxone-resistant Enterobacteriaceae: a molticentre study in French hospitals F. W. Goldstein*, Y. Pean*, A. Rosato', J. Gertner*,
More informationJournal of Infectious Diseases and
Journal of Infectious Diseases & Therapy ISSN: 2332-0877 Journal of Infectious Diseases and Therapy Santanirand et al., J Infect Dis Ther 2018, 6:5 DOI: 10.4172/2332-0877.1000378 Research Article Open
More informationPharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of
Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of Cefoperazone Sulbactam Singh M*, Kochhar P* Medical & Research Division, Pfizer India. Summary Antimicrobial resistance is associated with
More informationβ- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication
Prevalence of Carbapenem-Hydrolyzing β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication David Alcid M.D Balaji Yegneswaran M.D. Wanpen Numsuwan Introduction Klebsiella pneumoniae
More informationST11 KPC-2 Klebsiella pneumoniae detected in Taiwan
AAC Accepts, published online ahead of print on 30 January 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.05576-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5
More informationDownloaded from ismj.bpums.ac.ir at 10: on Friday March 8th 2019
- ( ) - * :... (MDR) (ESBLs: Extended-Spectrum Beta Lactamases). :.. (CLSI:Clinical and Laboratory Standards Institute). ESBL. combined disk method ESBL : / / / / / B / ( /). / / combined disk method.
More informationAffinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED
AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationGuidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011
Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review
More informationExpert rules. for Gram-negatives
Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University
More informationClinical and Bacteriological Study of Nosocomial Infections
JOURNAL OF CLIMCAL MICROBIOLOGY, Jan. 1993, p. 123-127 0095-1137/93/010123-05$02.00/0 Copyright ) 1993, American Society for Microbiology Vol. 31, No. 1 Clinical and Bacteriological Study of Nosocomial
More informationHOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION
Appendix 1: Carbapenem-Resistant Enterobacteriacaea (CRE) I. Definition: 2015 CDC definition of CRE are Enterobacteriaceae 1 that are: A. Resistant to any carbapenem antimicrobial (i.e., minimum inhibitory
More informationSurveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia
Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 41 41 Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia IRINA
More informationCarbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School
Carbapenemases in Enterobacteriaceae: 2012 Prof P. Nordmann Bicêtre hospital, South-Paris Med School March 21, 2012 Trends in Molecular Medecine NDM IMP OXA-48 KPC VIM ALERT VI M KPC KPC NDM I MP OXA-
More information10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP
National Center for Emerging and Zoonotic Infectious Diseases Emerging Resistance Updates Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention and Response Branch
More informationStrain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study
Uemura et al. BMC Infectious Diseases (2017) 17:26 DOI 10.1186/s12879-016-2144-4 RESEARCH ARTICLE Open Access Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology
More informationEVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS
Indian Journal of Medical Microbiology, (2005) 23 (2):120-124 Brief Communication EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS S Singhal, T
More informationAntibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)
Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336
More informationEpidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region
Epidemiology of the β-lactamase resistome among Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in the Chicago region Michael Y. Lin MD MPH 1, Karen Lolans BS 1, Rosie D. Lyles,
More informationA Two-Year Analysis of Risk Factors and Outcome in Patients with Bloodstream Infection
Jpn. J. Infect. Dis., 56, 1-7, 2003 Original Article A Two-Year Analysis of Risk Factors and Outcome in Patients with Bloodstream Infection Andrea Endimiani, Antonio Tamborini, Francesco Luzzaro, Gianluigi
More informationClinical significance of extended-spectrum
Clinical significance of extended-spectrum β-lactamases Expert Rev. Anti Infect. Ther. 6(5), 671 683 (2008) Jesús Rodríguez-Baño and Alvaro Pascual Author for correspondence Sección de Enfermedades Infecciosas,
More informationEmergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals
ORIGINAL ARTICLE Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals Clin Microbiol Infect 1999; 5: 622-627 Olivier Ronveaux, Yves De Glzeldre,
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationUrinary Tract Infections: From Simple to Complex. Adriane N Irwin, MS, PharmD, BCACP Clinical Assistant Professor Ambulatory Care October 25, 2014
Urinary Tract Infections: From Simple to Complex Adriane N Irwin, MS, PharmD, BCACP Clinical Assistant Professor Ambulatory Care October 25, 2014 Learning Objectives Develop empiric antimicrobial treatment
More informationHOSPITAL INFECTION CONTROL
HOSPITAL INFECTION CONTROL Objectives To be able to define hospital acquired infections discuss the sources and routes of transmission of infections in a hospital describe methods of prevention and control
More informationAbstract. Introduction
ORIGINAL ARTICLE INFECTIOUS DISEASES Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care
More informationPoor Predictive Ability of Urinalysis and Microscopic Examination to Detect Urinary Tract Infection
Microbiology and Infectious Disease / POOR PREDICTIVE ABILITY OF URINALYSIS Poor Predictive Ability of Urinalysis and Microscopic Examination to Detect Urinary Tract Infection Joy D. Van Nostrand, MS,
More informationCTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia
braz j infect dis. 2012;16(5):420 425 The Brazilian Journal of INFECTIOUS DISEASES www.elsevier.com/locate/bjid Original article CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from
More informationCeftazidime-Avibactam and Aztreonam an interesting strategy to Overcome β- Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae
AAC Accepted Manuscript Posted Online 19 June 2017 Antimicrob. Agents Chemother. doi:10.1128/aac.01008-17 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 3 Ceftazidime-Avibactam
More informationTreatment Options for Urinary Tract Infections Caused by Extended-Spectrum Β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
Treatment Options for Urinary Tract Infections Caused by Extended-Spectrum Β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae medicine.missouri.edu/jahm/treatment-options-urinary-tract-infections-caused-extended-spectrum-β-lactamase-producingescherichia-coli-klebsiella-pneumoniae/
More informationEmergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Sophie Vaux, Anne Carbonne, Jean-Michel Thiolet, Vincent Jarlier, Bruno Coignard, the RAISIN and Expert Laboratories Group
More informationChoc septique. Frédéric Pène
Choc septique Frédéric Pène Réanimation Médicale, Hôpital Cochin, AP-HP Université Paris Descartes Institut Cochin, Inserm U1016, CNRS UMR-8104, Département 3i No conflict of interest A 54 y.o. male patient
More informationPotential Conflicts of Interests
Potential Conflicts of Interests Research Grants Agency for Healthcare Research and Quality Akers Bioscience, Inc. Pfizer, Inc. Scientific Advisory Boards Pfizer, Inc. Cadence Pharmaceuticals Kimberly
More informationDetermining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing
AAC Accepted Manuscript Posted Online 8 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00838-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 1 2 Determining the
More informationIn Vitro Susceptibility Pattern of Cephalosporin- Resistant Gram-Negative Bacteria
In Vitro Susceptibility Pattern of Cephalosporin- Resistant Gram-Negative Bacteria Warunee Punpanich MD*, Worraporn Tantichattanon MD**, Siriporn Wongwatcharapaiboon MD**, Vipa Treeratweeraphong BSc, MSc***
More informationOriginal Article - Infection/Inflammation. Sungmin Song, Chulsung Kim, Donghoon Lim.
www.kjurology.org http://dx.doi.org/10.4111/kju.2014..4.20 Original Article - Infection/Inflammation http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014..4.20&domain=pdf&date_stamp=2014-04-1 Clinical
More informationGuidelines. 14 Nov Marc Bonten
Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.
More informationRegional Emergence of VIM producing carbapenem resistant Pseudomonas aeruginosa (VIM CRPA)
National Center for Emerging and Zoonotic Infectious Diseases Regional Emergence of VIM producing carbapenem resistant Pseudomonas aeruginosa (VIM CRPA) Chris Prestel, MD Epidemic Intelligence Service
More informationInfection Control Strategies to Avoid Carbapenam Resistance in Hospitals. Victor Lim International Medical University Malaysia
Infection Control Strategies to Avoid Carbapenam Resistance in Hospitals Victor Lim International Medical University Malaysia Outline of Lecture 1. Carbapenam resistance 2. Epidemiology of carbapenam resistance
More informationTHE EFFECT OF DIABETES MELLITUS ON THE CLINICAL AND MICRO-BIOLOGICAL OUTCOMES IN PATIENTS WITH ACUTE PYELONEPHRITIS
American Journal of Infectious Diseases 10 (2): 71-76, 2014 ISSN: 1553-6203 2014 Science Publication doi:10.3844/ajidsp.2014.71.76 Published Online 10 (2) 2014 (http://www.thescipub.com/ajid.toc) THE EFFECT
More informationReceived 21 September 1999/Returned for modification 26 November 1999/Accepted 18 February 2000
JOURNAL OF CLINICAL MICROBIOLOGY, May 2000, p. 1791 1796 Vol. 38, No. 5 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Occurrence and Detection of AmpC Beta-Lactamases
More informationβ-lactamase inhibitors
β-lactamase inhibitors Properties, microbiology & enzymology DAVID M LIVERMORE Professor of Medical Microbiology, UEA Lead on Antibiotic Resistance, Public Health England β-lactamase classes A B C D Serine
More informationOutcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
ORIGINAL ARTICLE BACTERIOLOGY Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections D. Ben-David, R. Kordevani, N. Keller, I. Tal, A. Marzel, O. Gal-Mor, Y. Maor and G. Rahav Infectious
More informationA Snapshot of Colistin Use in South-East Europe and Particularly in Greece
A Snapshot of Colistin Use in South-East Europe and Particularly in Greece Helen Giamarellou 02.05.2013 When Greek Physicians Prescribe Colistin? It is mainly prescribed in the ICU for VAP, bacteremia
More informationCephalosporin MIC Distribution of Extended-Spectrum- -Lactamaseand pampc-producing Escherichia coli and Klebsiella Species
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2009, p. 2419 2425 Vol. 47, No. 8 0095-1137/09/$08.00 0 doi:10.1128/jcm.00508-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Cephalosporin
More informationComparision of Antibiotic Susceptibility Testing As Per CLSI and Eucast Guidelines for Gram Negative Bacilli
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 7 Ver. X (July. 2016), PP 01-05 www.iosrjournals.org Comparision of Antibiotic Susceptibility
More informationThe Year in Infection Control
The Year in Infection Control Andie Lee Departments of Infectious Diseases and Microbiology Royal Prince Alfred Hospital Sydney, Australia 1 1.223 million Pubmed publications last 12 months 2 Selection
More information#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore
AAC Accepts, published online ahead of print on 21 October 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01754-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Title: Escherichia
More informationComparative Activity of Cefotaxime and Selected f3-lactam Antibiotics Against Haemophilus Influenzae and Aerobic Gram-Negative Bacilli
REVIEWS OF INFECTIOUS DISEASES VOL. 4, SUPPLEMENT SEPTEMBER-OCTOBER 1982 1982 by The University of Chicago. All rights reserved. 0162-0886/82/0405-0015$02.00 Comparative Activity of Cefotaxime and Selected
More informationDownloaded from ijmm.ir at 7: on Saturday October 13th Kirby Bauer Microbroth Dilution
ramin_abiri@yahoo.com Kirby Bauer Microbroth Dilution MIC 50 P< 0/005 SIM cfu/ml G N= (Z 1- /2) P (1-P)/d 2 d P mm / cfu/ml cfu/ml / Z (P(1-P )(1/n1 1/n2) = ( P1 P2 P2)/ P1 P n Z P value 2 MIC 90(µg/ml)
More informationExpert rules in antimicrobial susceptibility testing: State of the art
Expert rules in antimicrobial susceptibility testing: State of the art ESCMID Postgraduate Education Course Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic Hospital Universitario
More informationOriginal Article Mahidol Univ J Pharm Sci 2015; 42 (4), MT. Nguyen 1, TD. Dang Nguyen 1* 1
Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), 195-202 Investigation on hospital-acquired pneumonia and the association between hospital-acquired pneumonia and chronic comorbidity at the Department
More informationORIGINAL INVESTIGATION. Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City
ORIGINAL INVESTIGATION Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City A New Threat to Our Antibiotic Armamentarium Simona Bratu, MD; David Landman, MD; Robin Haag, RN; Rose
More informationESCMID Online Lecture Library. by author
www.eucast.org EXPERT RULES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA Departamento de Microbiología II Universidad
More informationCefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
Fukuchi et al. BMC Infectious Diseases (2016) 16:427 DOI 10.1186/s12879-016-1770-1 RESEARCH ARTICLE Open Access Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationHaut Conseil de la santé publique - French High Council for Public Health OPINION
Haut Conseil de la santé publique - French High Council for Public Health OPINION Additional information regarding the measures to control the spread of emergent highly-resistant bacteria (ehrb) recommended
More information1) 1) 1) 2) 2) (ICU) Key words: (ICU), ( ) 1 30 TEL: FAX: Vol. 17 No
2007 277 1) 1) 1) 2) 2) 3) 4) 5) 6) 1) 2) 3) 4) 5) 6) 18 10 17 19 8 20 16 7 1 (ICU) 20 2x 1.6 2.2 2SD 14 1 4 1 10 7 3 2 9 7.6; 95 2.37 24.62 6 4 5 1 DNA SpeI 9 2 A 7 B 2 A 3 B 1 ICU ICU 7 20 10 5 Key words:
More informationClinical Epidemiology of Gram-Negative Bacilli Bacteremia in a U.S. Teaching Hospital. The Impact of Multi-drug Resistance on Outcome
Clinical Epidemiology of Gram-Negative Bacilli Bacteremia in a U.S. Teaching Hospital The Impact of Multi-drug Resistance on Outcome By Christopher Hostler A Master s Paper submitted to the faculty of
More informationEXTENDED-SPECTRUM BETA-LACTAMASE PRODUCTION AMONG AMPICILLIN-RESISTANT ESCHERICHIA COLI STRAINS FROM CHICKEN IN ENUGU STATE, NIGERIA
Brazilian Journal of Microbiology (2007) 38:681-686 ISSN 1517-8382 EXTENDED-SPECTRUM BETA-LACTAMASE PRODUCTION AMONG AMPICILLIN-RESISTANT ESCHERICHIA COLI STRAINS FROM CHICKEN IN ENUGU STATE, NIGERIA Chah,
More informationINVESTIGATION OF EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING KLEBSIELLA PNEUMONIAE OUTBREAKS IN HUNGARY BETWEEN 2005 AND 2008
Acta Microbiologica et Immunologica Hungarica, 57 (1), pp. 43 53 (2010) DOI: 10.1556/AMicr.57.2010.1.4 INVESTIGATION OF EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING KLEBSIELLA PNEUMONIAE OUTBREAKS IN HUNGARY
More informationAnalysis of the common opportunistic pathogens
2009 12 4 4 Journal of Microbes and Infection, December 2009, Vol. 4, No. 4 241 1, 3 1, 2, 3, 1. ( ), 201508; 2., 200040; 3., 200032 :,,,,,,, ;, : ; ; Analysis of the common opportunistic pathogens SUN
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More informationCarbapenems and Enterobacteriaceae
Title Carbapenems and Enterobacteriaceae Presenter s details NHLS Dr Khine Swe Swe/Han FC Path ( Micro), SA MMed( micro), SA DTMH(Wits univ),sa PDIC(Stellen univ)sa MB,BS(Yangon),Myanmar Pathologist,Consultant/Lecturer,
More informationMICHIGAN MEDICINE GUIDELINES FOR TREATMENT OF URINARY TRACT INFECTIONS IN ADULTS
When to Order a Urine Culture: Asymptomatic bacteriuria is often treated unnecessarily, and accounts for a substantial burden of unnecessary antimicrobial use. National guidelines recommend against testing
More informationScreening of Carbapenem Resistant Enterobacteriaceae among Nosocomial Isolates: A Study from South India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 4 (2017) pp. 460-465 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.604.053
More informationRisk Factors for Methicillin-Resistant Staphylococcus aureus Colonization in a Geriatric Rehabilitation Hospital
Journal of Gerontology: MEDICAL SCIENCES 2007, Vol. 62A, No. 10, 1152 1156 Copyright 2007 by The Gerontological Society of America Risk Factors for Methicillin-Resistant Staphylococcus aureus Colonization
More informationAN OUTBREAK OF MULTIDRUG RESISTANT Salmonella typhimurium IN A NURSERY
AN OUTBREAK OF MULTIDRUG RESISTANT Salmonella typhimurium IN A NURSERY Ashok Kumar Gopal Nath B.D. Bhatia V. Bhargava V. Loiwal ABSTRACT A nursery epidemic caused by multidrug resistant Salmonella typhimurium
More informationCarbapenemase Producing Enterobacteriaceae: Screening
Carbapenemase Producing Enterobacteriaceae: Screening Dr David Harvey Consultant Microbiology and Infection Prevention and Control Nov 2015 Aims Is CPE a problem? Does screening have the potential to help?
More informationCorrespondence should be addressed to Yuan Gao; and Liangjing Lu; lu
BioMed Research International, Article ID 8296720, 9 pages https://doi.org/10.1155/2018/8296720 Research Article Infections Caused by Extended-Spectrum β-lactamase Producing Escherichia Coli in Systemic
More information